These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33085544)

  • 21. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
    Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
    Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma.
    Zhu P; Feng R; Lu X; Liao Y; Du Z; Zhai W; Chen K
    Aging (Albany NY); 2021 Jan; 13(3):4138-4156. PubMed ID: 33493134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of long non-coding RNA
    Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
    Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
    [No Abstract]   [Full Text] [Related]  

  • 24. The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma.
    Guo R; Dai H; Liu F; Liu M; Li X; Li T; Liao J; Chen ZS; Liu Y; Fang S
    Recent Pat Anticancer Drug Discov; 2022; 18(2):211-223. PubMed ID: 36045537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 27. Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma.
    Luo YH; Tang W; Zhang X; Tan Z; Guo WL; Zhao N; Pang SM; Dang YW; Rong MH; Cao J
    Medicine (Baltimore); 2017 Jul; 96(30):e7545. PubMed ID: 28746200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of
    Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
    Front Genet; 2022; 13():959832. PubMed ID: 36299588
    [No Abstract]   [Full Text] [Related]  

  • 29. Low expression of AQP9 and its value in hepatocellular carcinoma.
    Gao C; Shen J; Yao L; Xia Z; Liang X; Zhu R; Chen Z
    Transl Cancer Res; 2021 Apr; 10(4):1826-1841. PubMed ID: 35116505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A-3 gene as pivotal in hepatocellular carcinoma.
    Lin Y; Liang R; Mao Y; Ye J; Mai R; Gao X; Liu Z; Wainwright T; Li Q; Luo M; Ge L; Li Y; Zou D
    J Cell Biochem; 2020 Oct; 121(10):4094-4107. PubMed ID: 31898336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
    Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
    Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
    Yu H; Wang C; Ke S; Bai M; Xu Y; Lu S; Feng Z; Qian B; Xu Y; Zhou M; Li Z; Yin B; Li X; Hua Y; Zhou Y; Pan S; Fu Y; Ma Y
    Front Immunol; 2022; 13():892750. PubMed ID: 35812416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics analysis and experimental verification of five metabolism-related lncRNAs as prognostic models for hepatocellular carcinoma.
    Wang W; Deng Z; Jin Z; Wu G; Wang J; Zhu H; Xu B; Wen Z; Guo Y
    Medicine (Baltimore); 2022 Jan; 101(4):e28694. PubMed ID: 35089224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
    Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
    Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma.
    Zhan K; Bai Y; Liao S; Chen H; Kuang L; Luo Q; Lv L; Qiu L; Mei Z
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278494
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Xu J; Song J; Zeng X; Hu Y; Kuang J
    J Gastrointest Oncol; 2023 Apr; 14(2):516-532. PubMed ID: 37201083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
    Sun Q; Liu P; Long B; Zhu Y; Liu T
    Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma.
    Rao B; Li J; Ren T; Yang J; Zhang G; Liu L; Wang H; Huang M; Ren Z; Yu Z
    Front Cell Dev Biol; 2021; 9():686547. PubMed ID: 34350180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
    Xiong C; Wang G; Bai D
    Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
    Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
    Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.